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	 How	should	you	manage		
children	born	to	hepatitis	C-	
positive	women?	
EvidEncE-basEd answEr
A	 for starters, don’t	 be	 overly		 concerned	 with	 the	 mode	 of	 deliv-
ery;	it	doesn’t	influence	the	rate	of	transmis-
sion	 of	 hepatitis	 C	 virus	 (HCV),	 except	 in	
women	who	are	also	 infected	with	human	
immunodeficiency	virus	(HIV)	(strength	of	
recommendation	 [SOR]:	B,	 consistent	 ret-
rospective	cohort	studies).	
Avoid	 internal	 fetal	 monitoring	 and	
prolonged	rupture	of	membranes	(SOR:	B,	
single	retrospective	cohort	study).	
Advise	 patients	 that	 it’s	 OK	 to	 breast-
feed.	Breastfeeding	doesn’t	 affect	 transmis-
sion	(SOR:	B,	consistent	prospective	cohort	
studies).	
Check	 HCV	 RNA	 and	 serum	 anti-
HCV	 on	 2	 occasions	 between	 2	 and	 6	
months	 of	 age	 and	 18	 and	 24	 months	 of	
age	(SOR:	B,	consistent	prospective	cohort	
studies).	
Evidence summary
Perinatal	 transmission	 of	 HCV	 is	 rare.	 It	 oc-
curs	only	when	serum	HCV	RNA	is	detectable;	
transmission	 rates	 may	 be	 related	 to	 higher	
levels	 (>106	 copies/mL).1	 HCV	 is	 transmit-
ted	 to	2%	of	 infants	of	anti-HCV	seropositive	
women	and	4%	to	7%	of	infants	born	to	moth-
ers	who	are	HCV	RNA-positive	at	delivery.1	
Spontaneous	 clearance	 of	 the	 virus	 oc-
curs	in	approximately	20%	of	infants.	Most	re-
main	asymptomatic	if	HCV	persists,	but	have	
mild	elevation	of	liver	function	tests.2	
Routine	screening	 for	HCV	in	mothers	 is	
not	 recommended,	 but	 pregnant	 women	 at	
high	risk	for	HCV	infection	should	be	screened	
for	anti-HCV.	
Route of delivery:  
Only a concern for HIV-positive mothers
The	 mode	 of	 delivery	 doesn’t	 influence	 the	
rate	 of	 HCV	 transmission,	 except	 in	 moth-
ers	 with	 HIV.	 Retrospective	 analysis	 of	 503	
HCV-positive	 mothers	 coinfected	 with	 HIV	
showed	a	decreased	risk	of	transmission	dur-
ing	 cesarean	 delivery	 (odds	 ratio	 [OR]=0.36;	
P=.01;	 number	 needed	 to	 treat	 [NNT]=10).3
One	 study	 suggested	 an	 increased	 rate	 of	
vertical	 HCV	 transmission	 during	 vaginal	 de-
livery	compared	with	cesarean	delivery	(32%	vs	
6%;	P<.05).	The	study	didn’t	account	for	the	per-
cent	of	mothers	coinfected	with	HIV,	however.4	
A	 meta-analysis	 of	 11	 studies	 showed	
similar	 rates	 of	 transmission	 for	 vaginal	 and	
cesarean	 delivery:	 adjusted	 rates	 were	 4.3%	
and	3%,	respectively.1	
Internal monitoring is an issue
Avoid	 internal	 fetal	 monitoring	 to	 minimize	
HCV	 transmission,	 based	 on	 a	 single	 retro-
spective	 cohort	 of	 244	 infants	 born	 to	 HCV-
positive	mothers	 (relative	risk	 [RR]=	7.7;	95%	
confidence	 interval	 [CI],	 1.9-31.6;	 number	
needed	 to	 harm	 [NNH]=6).7	The	 same	 study	
showed	 an	 increased	 risk	 with	 membrane	
rupture	longer	than	6	hours	(RR=9.9;	95%	CI,	
1.2-81;	NNH=13).5	
Breastfeeding	doesn’t	 significantly	 affect	
HCV	 transmission.	 Transmission	 rates	 for	
breastfed	 and	 nonbreastfed	 infants	 are	 3.7%	
and	3.9%,	respectively.1
coNTINuEd
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Defer postpartum lab testing
Because	about	20%	of	infants	exposed	to	HCV	
clear	 the	 virus	 spontaneously,	 and	 maternal	
antibodies	 can	 confound	 laboratory	 results,	
deferring	postpartum	diagnostic	 testing	 is	ap-
propriate.	 A	 study	 of	 1104	 children	 in	 whom	
vertical	 transmission	 didn’t	 occur	 after	 ex-
posure	 to	 HCV	 showed	 that	 95%	 of	 the	 chil-
dren	 were	 anti-HCV	 antibody	 negative	 by	
12	months	age.6	A	prospective	 study	of	23	 in-
fants	 documented	 spontaneous	 clearance	 of	
HCV	RNA	by	6	months	in	all	patients.7
Recommendations 
The	 National	 Institutes	 of	 Health	 2002	 Con-
sensus	Statement	recommends:8
	 •	 	avoiding	 fetal	 scalp	 electrodes	 and	 pro-
longed	rupture	of	membranes
	 •	 	serum	testing	 for	HCV	RNA	at	2	months	
and	6	months	of	age
	 •	 	anti-HCV	 antibody	 testing	 after	 15	
months	of	age.
The	 American	 College	 of	 Obstetricians	
and	 Gynecologists	 supports	 breastfeeding,	
recommends	against	routine	HCV	screening,	
and	 recommends	 that	 cesarean	 delivery	 be	
reserved	for	obstetric	indications.9	
The	 American	 Association	 for	 the	 Study	
of	 Liver	 Diseases	 recommends	 serum	 testing	
and	liver	biopsy	on	the	same	schedule	as	adult	
patients	 and	 endorses	 considering	 treatment	
after	3	years	of	age.6	
The	US	Food	and	Drug	Administration	has	
approved	treatment	after	3	years	of	age	for	chil-
dren	 with	 detectable	 HCV	 RNA	 levels	 higher	
than	50	IU/mL	and	who	have	had	a	liver	biop-
sy	with	portal	or	bridging	fibrosis	and	at	 least	
moderate	inflammation	and	necrosis.
The	American	Gastroenterological	Asso-
ciation	 recommends	 considering	 treatment	
with	PEG-interferon	and	ribavirin	after	3	years	
of	age.10				 	 	 															JFP
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•	 	How	can	nursing	moms	get	relief	from	nipple	pain?	
•	 	What’s	the	best	way	to	monitor	low-risk	patients	with	
a	history	of	differentiated	thyroid	cancer?
